Sign inJoin waitlistJoin the waitlist

Srihari Veeraraghavan

Director of the Interstitial Lung Disease Program · Emory

Credentials: · · · · · ·

History

Emory University School of Medicine
Present
Emory University School of Medicine
Present
Emory University School of Medicine
Present

Royal Brompton hospital
1999–2000
University of Southern California
1996–1999
University Hospital of Brooklyn
1992–1994
Kilpauk Medical College
1988–1992

Research

Interstitial lung disease in systemic sclerosis: a simple staging system
American Journal of Respiratory and Critical Care Medicine · 2008 · 906 citations
Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends
American Journal of Respiratory and Critical Care Medicine · 2003 · 453 citations
CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Radiology · 2004 · 268 citations

Brent Little
7 papers
Travis Henry
5 papers · 4 as a resident
Eugene Berkowitz
4 papers
OS
Om Sharma
4 papers
Frank McCormack
3 papers
JK
Jordan Kempker
3 papers
MK
Michael Koss
3 papers
Mohleen Kang
3 papers · 2 as a fellow
TC
Thomas Colby
3 papers
Charles Burger
2 papers
CM
Cristopher Meyer
2 papers
Daniel Dilling
2 papers

Clinical trials

Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Principal investigator · Completed · Phase 2
Kyntra Bio
2013–2017
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Site PI · Recruiting · Phase 3
United Therapeutics
2023–2027
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Site PI · Recruiting
Duke University
2014–2031